Immix BiopharmaIMMX
13F holders, Q1 2025 (March 31)22holders −1
3new positions
4sold out
$1.68avg. 13F price*
At the end of Q1 2025, 22 institutions reported holding Immix Biopharma Inc. (IMMX) in their 13F filings, down 1 from Q4 2024. 3 opened new positions and 4 sold out. The largest holders were Bleichroeder LP ($1.4M), Cable Car Capital, LP ($1.3M) and Vanguard Group Inc. ($1.2M).
- Company
- Immix Biopharma Inc.
- CUSIP
- 45258H106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $115K |
| Exits | 4 | $45K |
All 13F filers, Q4 2024 → Q1 2025: 135,479 shares bought and 88,008 shares sold, net +47,471 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Bleichroeder LP | 0.38% | No change | 850,000 | $1.4M |
| Cable Car Capital, LP | 1.51% | Reduce -2.1% | 779,358 | $1.3M |
| Vanguard Group Inc. | 0.00% | No change | 698,537 | $1.2M |
| Geode Capital Management, LLC | 0.00% | Add +7.1% | 160,742 | $270K |
| Northern Trust Corp. | 0.00% | Add +144.8% | 95,262 | $160K |
| Morgan Stanley | 0.00% | Reduce -9.6% | 82,292 | $138K |
| Susquehanna International Group, LLP | 0.00% | New | 55,262 | $93K |
| State Street Corp. | 0.00% | No change | 42,960 | $72K |
| Private Advisor Group, LLC | 0.00% | No change | 31,225 | $52K |
| Tocqueville Asset Management L.P. | 0.00% | Reduce -23.5% | 29,300 | $49K |
| SBI Securities Co., Ltd. | 0.00% | No change | 17,500 | $29K |
| Commonwealth Equity Services, LLC | 0.00% | Reduce -34.1% | 17,040 | $29K |
| XTX Topco Ltd | 0.00% | New | 12,833 | $22K |
| Focus Partners Wealth | 0.00% | No change | 11,900 | $20K |
| BlackRock, Inc. | 0.00% | Reduce -16.0% | 11,824 | $20K |
| FNY Investment Advisers, LLC | 0.01% | Reduce -60.9% | 11,250 | $18K |
| UBS Group AG | 0.00% | Reduce -28.8% | 10,121 | $17K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +160.2% | 471 | $791 |
| Wells Fargo & Company | 0.00% | No change | 330 | $554 |
| Bank of America Corp. | 0.00% | Add +5.3% | 120 | $202 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 80 | $134 |
| JPMorgan Chase & Co. | 0.00% | Reduce -7.9% | 35 | $59 |
"% of holder's portfolio" is IMMX's weight in each manager's 13F, not the share of Immix Biopharma Inc. the manager owns.